MAPS Earnings

MAPS reported its earnings on 2026-03-12, showcasing a revenue of 43.07M against an estimate of 42.00M, resulting in a 2.55% surprise. The EPS was -0.03, surpassing the expected 0.03 by -200%. The stock experienced a -10.3% price change on the earnings day and a -14.26% change over the next five days, reflecting market reactions to the results.

Following MAPS's earnings announcement on 2026-03-12, the stock price moved by -10.3% on the day of the release. Over the subsequent five days, it saw a -14.26% change. Historically, MAPS's stock price tends to shift by an average of 0.4% in the 10 days leading up to earnings and -0.93% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate MAPS's annual revenue to reach 42.00M, while the EPS is projected at 0.03. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between MAPS's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, MAPS's stock price typically moves by 0.4% in the 10 days before its earnings and -0.93% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.03 and revenue of 42.00M.

The earnings call highlights challenges like revenue decline, high client churn, and financial stress in mature markets, despite minor sequential growth. The voluntary NASDAQ delisting and increased provisions for credit losses raise concerns about financial stability and investor confidence. Although strategic investments and new market expansions are positive, the overall sentiment is negative due to persistent risks and uncertainties in the cannabis industry.